Bayit Vegag 2025: Permits are moving, but the cash test is still ahead
Bayit Vegag entered 2026 with more projects already in execution and an important planning push at Bat Galim, but operating cash flow was still negative and a meaningful part of sales relied on deferred-payment terms. The real test now is whether permits and inventory turn into cash.
Understanding the Company
Bayit Vegag is not just another residential developer reporting inventory, permits and a big pipeline while waiting for the market to improve. Its economics depend on moving projects from signatures to planning, from planning to permits, from permits to financing, and from financing to deliveries and cash. That is why the key number in this report is not only ILS 109.6 million of revenue or a net loss of ILS 13.8 million. The real test is whether the large project pipeline that already exists on paper is starting to turn into an execution chain that reduces dependence on external funding.
What is working right now is clear. During 2025, Ahimeir, Jabotinsky 133 and Jabotinsky 135-137 moved into execution, Jabotinsky 152 received a building permit, Bat Galim in Haifa received conditional approval for a full permit, and in July 2025 the company completed a bond issue with ILS 104.7 million par value. That is not cosmetic progress. It means more projects moved from promise to a stage where timelines, contractors, financing lines and pledged surplus can actually be measured.
But this is still not a clean story. Revenue fell by about 20%, operating cash flow stayed negative at ILS 88.4 million, and about half of apartment sales in projects where marketing has started are being done on deferred-payment structures such as 20/80, 30/70 and 15/85, sometimes together with full or partial indexation relief and even mortgage-rate subsidies. In plain terms, Bayit Vegag managed to keep project momentum and some sales pace, but in a meaningful share of cases it is doing so through commercial terms that weaken revenue quality and delay cash conversion.
That is why 2026 looks like a bridge year with a proof requirement. For the read on the company to improve, the market needs to see a full permit and financing at Bat Galim, a real move by HaAmoraim and Jabotinsky 152 from planning into execution, and genuine cash-flow improvement without relying mainly on fresh debt again. Until that happens, a company with only a few hundred million shekels of market value and extremely weak daily liquidity does not give investors much room for error.
Quick Economic Map
| Layer | Key number | Why it matters |
|---|---|---|
| Execution pipeline | 6 projects under construction with 543 new units | This is the revenue base for the next two years |
| Planning pipeline | 11 advanced-planning projects with 1,751 units | This is where the next step-up sits, but not the cash yet |
| Conditional and potential pipeline | 33 conditional projects with 4,093 units and about 10 potential projects with 4,951 units | Impressive on paper, still economically distant |
| Signed backlog | ILS 218.7 million of expected recognized revenue versus ILS 252.0 million of expected receipts | There is some visibility, but the accounting timeline and the cash timeline do not match |
| Liquidity | ILS 77.8 million of cash plus ILS 51.0 million of restricted deposits | There is time, but not a cushion that removes financing dependence |
| Human platform | 36 employees at year-end 2025 | This is a relatively small execution platform managing a large project stack |
| Active bottleneck | Moving from permit and early marketing to financing, execution and delivery | This is what will determine whether inventory turns into money |
Events and Triggers
First trigger: Haifa moved from an abstract planning story to a timetable the market can actually track. Bat Galim, an urban-renewal project with 715 new apartments and 16 commercial units, received conditional approval for a full building permit in December 2025. For the company, that matters far more than a headline. It means the zoning and design stage are already behind it, and the question now is no longer whether a plan exists but whether the remaining conditions will be completed, financing will be signed, and construction will actually start in the fourth quarter of 2026 as management estimates.
Second trigger: The Tel Aviv projects that already entered execution changed the balance sheet almost overnight. Ahimeir received a permit in September 2024 and began construction in March 2025. Jabotinsky 133 and Jabotinsky 135-137 received permits in the fourth quarter of 2025, while construction had already started in the second quarter of the year. At the same time, Jabotinsky 152 received a permit in June 2025, the building was vacated, and work is expected to start in March 2026. That creates a more credible active-project base, but it also explains why inventory, debt and landowner liabilities rose so sharply.
Third trigger: The bond bought time, not a solution. Series A was issued in early July 2025 at a fixed 5.68% coupon, with principal repayments between September 2028 and March 2030. By year-end 2025, the carrying value of the liability stood at ILS 103.3 million. This improved financing flexibility, but it also locked in another layer of fixed interest expense and project-specific collateral.
Fourth trigger: In 2025 the company did not just advance projects. It also exposed how much of the value is still not accessible. HaAmoraim in Tel Aviv already had a signed main-contractor agreement in February 2025 and is expected to receive a permit in the second quarter of 2026, but by year-end 2025 there were no recognized sales there and only one early-sale contract by the report date. Bat Galim still had no sales at all. So a large part of the future economic value is already presented in the expected gross-profit tables, but it still has not reached the stage where it starts producing cash.
Efficiency, Profitability and Competition
The 2025 operating picture looks weak in the headline, but it is less weak in the details. Revenue fell to ILS 109.6 million from ILS 136.4 million in 2024, cost of sales fell to ILS 89.5 million from ILS 110.7 million, and gross profit declined to ILS 20.2 million from ILS 25.7 million. Gross margin only slipped modestly, to 18.4% from 18.8%. In other words, the damage came first from lower recognized volume, not from a collapse in pricing or unit economics across the portfolio.
The main reason is straightforward. In 2025 fewer projects were contributing recognized revenue than in 2024. The prior year still included Remez, Bart and HaGefen alongside Bezalel, Lipski and Simtat HaMaalot. In 2025, revenue came mainly from Bezalel, Simtat HaMaalot, Lipski and Ahimeir, and only marginally from Jabotinsky 133 and 135-137, whose construction only started to matter late in the year. That is why inventory expanded while the income statement still did not capture the full operational move.
What Actually Happened in the Latest Quarter
Anyone looking only at the full year misses that the fourth quarter already looked better. Quarterly revenue rose to ILS 29.6 million from ILS 25.0 million in the comparable quarter, gross profit rose to ILS 7.8 million from ILS 7.4 million, and the operating loss narrowed to ILS 1.4 million from ILS 3.0 million. That is not a full inflection yet, but it is a sign that the migration of more projects into execution is starting to show up.
Who Is Funding the Sales Pace
This is the core issue. The company explicitly says that about half of apartment sales in projects where marketing has started are done on payment structures where a meaningful part of the consideration is deferred to delivery, and in some cases buyers also receive indexation relief or subsidized mortgage terms through contractor loans. The company also says those terms effectively embed a discount in the apartment price. That is a material point because it means sales are being maintained not only through natural demand, but also through commercial support.
That is also why finance income rose to ILS 7.4 million from ILS 5.6 million. Part of the increase did not come from a new financing business but from the significant financing component that is recognized in sales contracts when customer payment timing does not match the construction curve. In simple terms, part of the economic cost of preserving sales pace moves below the revenue line and into finance income. So contract count alone is not enough.
There is another small but telling clue here. In the macro section, the annual report says the company signed 27 sale contracts during 2025 for a total of about ILS 153 million including VAT, while the projects section counts 28 contracts including early-sale agreements. That discrepancy is not thesis-breaking, but it does reinforce the right lesson: the important metric is not the headline that X apartments were sold, but which contracts were signed, at what stage, and on what terms.
Where Competition Really Bites
Bayit Vegag operates in high-demand areas, mainly Tel Aviv and the center of the country. Its competitive edge is less about owning legacy land and more about signing tenants, managing planning, securing financing and running an engineering platform. That is a real advantage. But it is not the kind of moat that cancels the cycle. As long as rates remain high, permitting stays slow and the banking system is stricter on deferred-payment deals, execution capability alone is not enough to turn a large pipeline into clean earnings.
Cash Flow, Debt and Capital Structure
Here the cash lens has to be explicit. In Bayit Vegag's case, the right frame is all-in cash flexibility. This is not a company where it makes sense to cleanly separate maintenance cash generation from growth cash generation, because the core story is funding inventory, tenant evacuation, equity injections into project finance and debt service at the group level. What matters is how much cash is left after real cash uses, not only how much economic profit is embedded in the projects.
On that basis, the picture is clear. In 2025 the company burned ILS 88.4 million in operating cash flow, got almost no help from investing cash flow, and offset the gap with ILS 128.8 million from financing activities. Cash rose to ILS 77.8 million from ILS 37.2 million, but that increase did not come from turning inventory into cash. It came from new bonds and bank project financing. That buys time. It does not prove the machine is already funding itself.
Why the Balance Sheet Expanded
Short-term inventory jumped to ILS 432.5 million from ILS 165.3 million. At the same time, obligations to landowners rose to ILS 199.3 million from ILS 24.2 million, and contract assets increased to ILS 77.2 million from ILS 45.9 million. This is not just a story of spending more money. A large share of the jump came from accounting recognition of land value and tenant obligations in Ahimeir, Jabotinsky 133, Jabotinsky 135-137 and Jabotinsky 152, and from moving projects such as Bat Galim and Migdal Raanana from long-term inventory into short-term inventory.
The implication is that value creation is progressing, but not every increase in inventory means more cash is on the way. Quite the opposite. Part of the balance-sheet growth came because projects crossed an accounting threshold, not because the company monetized value or received cash. This is exactly the difference between value that has been created and value that is actually accessible to shareholders.
Formal Liquidity Versus Real Liquidity
On paper, the company ended 2025 with ILS 673.3 million of current assets against ILS 388.5 million of current liabilities. That is not an immediate distress picture. But it is important to remember that this line relies mainly on inventory, contract assets and restricted deposits, not just on free cash. ILS 51.0 million sat in restricted deposits inside project financing accounts. So here too, the gap between balance-sheet liquidity and real liquidity matters.
Debt, Bondholders and Covenant Room
Series A added a fixed funding layer, but as of year-end 2025 the covenants were not tight. Equity under the bond indenture stood at about ILS 242 million against a minimum of ILS 115 million. Equity to assets stood at about 44% against a 13.5% floor, and the collateral ratio stood at about 70% against an 80% ceiling. Formal headroom exists.
The more important question is where the collateral actually sits. Bondholders are relying on pledged project surplus in four projects: about ILS 69.4 million in Ahimeir, about ILS 36.2 million in Jabotinsky 133, about ILS 22.9 million in Jabotinsky 135-137, and about ILS 23.3 million in Jabotinsky 152. In other words, even the bond itself is a fairly concentrated bet that specific projects will generate distributable surplus and release it upstream.
Forecasts and What Comes Next
Before looking ahead to 2026, the non-obvious findings need to be stripped down clearly:
- Inventory did not grow only because the company spent more. A meaningful part of the increase came from projects crossing an accounting threshold that pulled both land value and landowner obligations onto the balance sheet.
- The Bat Galim permit matters, but it is not yet a cash event. There are still no sales there, no financing yet, and construction is only expected to start after a full permit in the third quarter of 2026.
- Sales quality is softer than the headline suggests. Roughly half of the deals where marketing has started involve meaningful payment deferrals, sometimes together with indexation relief or subsidized financing.
- The fourth quarter already improved, but the 2026 earnings base is still not backed by cash.
That leads to one conclusion: 2026 looks like a bridge year with a proof test, not a breakout year. For it to become a breakout year, Bayit Vegag needs to show at least three things at once: the Tel Aviv execution projects continue without a material margin hit, the key planning projects actually move into permits and execution, and sales pace does not depend only on unusually soft financing terms.
What Is Already in the Pipeline
From signed contracts, the company expects to recognize about ILS 92.7 million of revenue in 2026, another ILS 84.0 million in 2027, and about ILS 42.0 million from 2028 onward. Expected customer receipts look very different: about ILS 102.5 million in 2026, only ILS 17.9 million in 2027, and then a jump to ILS 131.6 million from 2028 onward. That gap again shows that the cash story and the revenue-recognition story are not the same thing.
Where the Future Value Sits
This is where created value and accessible value separate sharply. Bat Galim carries expected gross profit of ILS 190.8 million, but as of year-end 2025 there were still no signed sales there. HaAmoraim carries expected gross profit of ILS 68.5 million, but only one early-sale contract had been signed by the report date. Jabotinsky 152 carries expected gross profit of ILS 19.0 million, after expected gross margin fell sharply from 24.6% in 2023 to 14.2% in 2025. So the future value exists, but part of it has already compressed, and part of it is still very far from delivery and cash.
That is also why Bat Galim matters so much. The project can change the company's profile, but for now it still contributes mainly strategic optionality and expected accounting value, not cash flow. The same is true, in a smaller way, for HaAmoraim. There is already a contractor and a timetable, but without real sales it is still too early to build the 2026 story around it.
What Must Happen Over the Next 2 to 4 Quarters
The company needs to convert Bat Galim from a conditional permit into a full permit, sign financing and start work. It needs to move HaAmoraim and Jabotinsky 152 from projected starts into actual execution. And it needs to show that finance income associated with deferred customer payments is not growing faster than its ability to generate operating cash.
If that happens, the market may end up reading 2025 as the year the groundwork was laid for 2027 and 2028. If not, 2025 will be remembered as the year the project pipeline grew faster than the company's ability to fund and convert it.
Risks
The first risk is commercial financing risk, not only interest-rate risk. When the company says that about half of marketed-project sales involve material payment deferrals, it is effectively saying the market needs support. The Bank of Israel circular dated March 23, 2025 makes that point even sharper. It raises risk weights on project exposures where a high share of apartments is sold on deferred-payment terms and limits subsidized balloon-loan activity. That is a clear external signal that the regulator itself views this mechanism as a source of credit risk.
The second risk is execution risk. The company explicitly points to labor shortages, cost inflation and the risk of delays, including compensation exposure if deliveries slip. It also says it has already dealt with contractor collapses in the past and materially changed the structure of its engineering function and supervision level. That helps, but it does not remove the risk.
The third risk is permit and maturation risk. Bat Galim looks advanced, but it is still contingent on satisfying conditions and signing financing and contractor agreements. HaAmoraim is still pre-permit. A stack of 33 conditional projects sounds strong, but a meaningful part of it can be delayed for years.
The fourth risk is market actionability. In early April 2026 the stock traded with daily turnover of only about ILS 10.7 thousand. That is a real practical filter. Even if the thesis improves, the way the market prices the company can remain choppy and inefficient simply because of thin liquidity.
Short Interest Read
Short-interest data do not show a deep bearish market thesis right now. At the end of March 2026, short float stood at only 0.04%, with SIR of 0.1, far below the sector averages of 0.83% and 2.927 respectively. There was a temporary spike in January 2026 to 2.09% of float and 7.24 SIR, but it disappeared quickly.
My read is straightforward. Market skepticism around Bayit Vegag currently comes more from thin liquidity and caution around execution than from an aggressive short build.
Conclusions
Bayit Vegag finished 2025 with more projects at an advanced stage and a more flexible funding structure than it had a year earlier, but with the same core test still unresolved: will permits, inventory and contracts actually turn into cash, or just into another layer of accounting value. What supports the thesis right now is the migration of several projects into execution and the clear change in timing at Bat Galim. What blocks a cleaner read is sales quality and cash flow. What will shape the market's near-term interpretation is whether 2026 brings full permits, financing and actual construction starts, not just more pipeline slides.
Current thesis in one line: Bayit Vegag is no longer just collecting planning-stage options, but it still has not proven that the move into execution releases cash at a pace that supports a cleaner story.
What changed versus the prior read of the company: 2025 pushed more projects from promise into execution and the bond bought time. At the same time, the report made it clear how much of the balance sheet and the sales line still rest on deferred-payment terms and on value that remains trapped in not-yet-monetized projects.
The strongest counter-thesis: The market may be too harsh on the transition phase. If Bat Galim receives a full permit on time, HaAmoraim and Jabotinsky 152 actually move into construction, and Ahimeir plus the Jabotinsky projects keep progressing without another margin hit, the company may look in hindsight like it already passed the peak cash-pressure year in 2025 rather than remaining stuck in it.
What could change the market read in the short to medium term: a full permit and financing at Bat Galim, real execution starts at HaAmoraim and Jabotinsky 152, and the first evidence that sales pace does not require another round of softer commercial terms.
Why this matters: In smaller residential developers, the gap between accounting value and accessible value is the whole story. Bayit Vegag advanced the value side in 2025, but it still has not closed that gap.
| Metric | Score | Explanation |
|---|---|---|
| Overall moat strength | 3.5 / 5 | Proven ability to build an urban-renewal pipeline in high-demand areas and move projects into permit and execution stages |
| Overall risk level | 3.5 / 5 | Negative cash flow, dependence on project financing and a high share of deferred-payment sales |
| Value-chain resilience | Medium | No dependence on a single contractor, but high dependence on permits, financing and labor availability |
| Strategic clarity | Medium | The direction is clear, monetize the pipeline and scale larger projects, but the cash path is still not clean |
| Short-interest stance | 0.04% short float | No meaningful short build right now, and the main market friction remains low liquidity rather than short pressure |
Over the next 2 to 4 quarters, the thesis strengthens if Bayit Vegag delivers a full permit and financing at Bat Galim, starts work at HaAmoraim and Jabotinsky 152, and improves cash flow without again leaning mainly on fresh debt. It weakens if permits slip, if commercial terms remain too soft, or if project progress keeps inflating inventory faster than it converts into cash.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.
Bayit Vegag's Series A is backed by rights to surplus from specific projects, but as of year-end 2025 that is still mainly future-release collateral rather than cash already accessible above the bank-financing layer.
Bat Galim moved at the end of 2025 from advanced planning into a conditional full-permit stage, but it still lacks the critical execution links, full signatures, project financing, a contractor and sales, so it is not yet a project that has started producing.
Bayit Vegag is holding a meaningful part of its sales pace through deferred-payment contracts, but that structure pushes customer cash receipts further out and leaves the cash-conversion test unresolved.